Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells

American Journal of Pathology

Volumn 160, Issue 5, 2002, Pages 1647-1654

  Horie, Ryouichi ^a,b   Watanabe, Takuro ^a   Ito, Kinji ^a   Morisita, Yasuyuki ^a   Watanabe, Mariko ^b   Ishida, Takaomi ^a   Higashihara, Masaaki ^b   Kadin, Marshall ^c   Watanabe, Toshiki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CYTOPLASM PROTEIN; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN NIK; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL MEMBRANE; CELL STRAIN; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LYMPH NODE; LYMPHOMA CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; REED STERNBERG CELL; SIGNAL TRANSDUCTION;

EID: 0036092336     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61112-1     Document Type: Article

References (37)

1. Tumor necrosis factor receptor-associated factor (TRAF) family: Adapter proteins that mediate cytokine signaling
2. The TNF-receptor-associated factor family: Scaffold molecules for cytokine receptors, kinases, and their regulators
3. MAP3K-related kinase involved in NF-κB induction by TNF
4. ASK1 is essential for JNK/SAPK activation by TRAF2
5. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
6. An essential role for NF-κB in preventing TNF-α-induced cell death
7. Regulation and function of the JNK subgroup of MAP kinases
8. Pathophysiology of Hodgkin's disease: Functional and molecular aspects
9. Hodgkin's lymphomas: Classification, diagnosis, and grading
10. Cytokines and cytokine receptors in Hodgkin's disease
11. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development
12. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells
13. Reed-Sternberg cell genome expression supports a B-cell lineage
14. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription
15. High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells
16. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
17. Defective IκBα in Hodgkin cell lines with constitutively active NF-κB
18. Mutation in IκBα gene in Hodgkin's disease suggest a tumor suppressor role for IκBα
19. Overexpression of IκBα without inhibition of NF-κB activity and mutations in the I κ B α gene in Reed-Sternberg cells
20. Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
21. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
22. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
23. CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy
24. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
25. CD30/TNF receptor-associated factor interaction: NF-κB activation and binding specificity
26. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins
27. Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2
28. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFκB activation
29. Ligand-independent signaling by overexpressed CD30 drive NF-κB activation in Hodgkin-Reed-Sternberg cells
30. A novel domain in the CD30 cytoplasmic tail mediates NFκB activation
31. Translocation of TRAF proteins regulates apoptotic threshold of cells
32. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 in Hodgkin's disease
33. CD30-dependent degradation of TRAF2: Implications for negative regulation of TRAF signaling and the control of cell survival
34. Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling
35. A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes
36. Hodgkin disease: Pharmacologic intervention of the CD40-NF-κB pathway by a protease inhibitor
37. CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex